Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi Biotec
  • MACS® Cell Analysis
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Gene expression profiling products Gene expression profiling products
miRNA expression profiling products miRNA expression profiling products
KIR typing KIR typing
Chimerism analysis Chimerism analysis
Protein isolation and analysis Protein isolation and analysis
HIV/virus isolation HIV/virus isolation
Mitochondria isolation Mitochondria isolation
Transfection & transduction Transfection & transduction
  MACSelect™ - Transfected Cell Selection Kits
  MACSelect™ Vectors and Tag Vector Sets
  MACSelect™ Antibodies
  Reagents for cell transduction
MACS® Separators and Columns MACS® Separators and Columns
Genomic services Genomic services
Miltenyi Biotec
MACS eNews
Subscribe to our
MACS eNews
for regular product information via e-mail.
Miltenyi Biotec
MACSelect™ Kk System
The MACSelect™ Kk System uses the truncated mouse MHC class I molecule H-2Kk as a selection marker. H-2Kk expression is restricted to some rarely used mouse strains, e.g. AKR/J or CBA/J. MACSelect Kk can be used in virtually any mammalian cell line and in primary cells. The H-2Kk marker should not be used when MHC class I expression is down-regulated either directly or via reduced expression of β2 microglobulin, e.g. in some tumor cell lines such as adenocarcinoma cell lines.

The pMACS Kk.II vector encodes the truncated H-2Kk surface marker and can be used for cloning the gene-of-interest. Additionally, it can be used for cotransfection in combination with a gene-of-interest expression vector.

The MACSelect Kk Transfected Cell Selection Kit provides the vectors, MACSelect MicroBeads, and fluorochrome-conjugated antibodies, including control vectors and antibodies required to set up and establish the MACSelect System. All kit components are also available separately.
Columns
For positive selection: MS, LS, or autoMACS® Columns.
Further information
vector map pMACS Kk.II (Single Cutting Restriction Sites)
[PDF; 63,3 KB]
DNA sequence pMACSKkII (RTF Document, MAC)
[RichTextFile (RTF); 7,9 KB]
vector map pMACS 14.1 (Single Cutting Restriction Sites)
[PDF; 20,3 KB]
vector map pMACS 14.1 (Twice Cutting Restriction Sites)
[PDF; 22,3 KB]
DNA sequence pMACS_Kk_HA(C) (RTF Document, MAC)
[RichTextFile (RTF); 5,5 KB]
DNA sequence pMACS_Kk_HA(N) (RTF Document, MAC)
[RichTextFile (RTF); 5,5 KB]
DNA sequence pMACS_Kk_c-myc(C) (RTF Document, MAC)
[RichTextFile (RTF); 5,5 KB]
DNA sequence pMACS_Kk_c-myc(N) (RTF Document, MAC)
[RichTextFile (RTF); 5,5 KB]
DNA sequence pMACS_Kk_His(C) (RTF Document, MAC)
[RichTextFile (RTF); 5,5 KB]
DNA sequence pMACS_Kk_His(N) (RTF Document, MAC)
[RichTextFile (RTF); 5,5 KB]
 
Figure 1
The pMACS Kk.II vector.
Figure 2
A, B, and C represent various cell numbers of CHO cells before and after enrichment for the enrichment of CHO cells. Cells were cotransfected with pMACS Kk.II and pMACS 14.1 encoding CD14 as the gene-of-interest.
Figure 3
MACSelect transfected cell enrichment
Miltenyi Biotec
Search this website
Advanced search
Toolbox
Customer login
Contact
Newsletter
Help
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
MACSelect Kk – Transfected Cell Selection Kit
- for 25 separations
Components
- 25 μg pMACS Kk.II
- 25 μg pMACS 14.1
- 0.25 mL MACSelect Control FITC Antibody
- 0.25 mL Anti-H-2Kk-FITC, mouse
- 0.25 mL CD14-FITC, human
- 2 mL MACSelect Kk MicroBeads
Download datasheet
130-091-986
Qty.:
 

pMACS Kk.II
Components
- 25 μg plasmid
Download datasheet
130-091-889
Qty.:
 

MACSelect Kk MicroBeads
- for 25 separations
Components
- 2 mL MACSelect Kk MicroBeads
Download datasheet
130-070-201
Qty.:
 

Related products
Anti-H-2Kk-FITC, mouse (#130-085-101)
CD14-FITC, human (#130-080-701)
MACSelect Control FITC Antibody (#130-090-326)
Dead Cell Removal Kit (#130-090-101)
References
1. Petry et al. (1999) Int. Immunol. 11: 753-763.
2. Tetsu and McCormick (1999) Nature 398: 422-426.
3. Porter et al. (2002) J. Immunol. 168: 4936-4945.
4. Finotto et al. (2001) J. Exp. Med. 193: 1247-1260.
Miltenyi Biotec
Miltenyi Biotec
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website